ISA Pharmaceuticals develops targeted, rationally designed immunotherapeutics for the treatment of cancer and persistent virus infections.
Location: Netherlands, South Holland, Oegstgeest
Employees: 11-50
Total raised: $30.78M
Founded date: 2004
Investors 1
| Date | Name | Website |
| - | Aglaia Onc... | aglaia-onc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 13.07.2021 | - | $30.78M | - |
Mentions in press and media 4
| Date | Title | Description |
| 13.07.2021 | ISA Pharmaceuticals Closes €26M Funding Round | ISA Pharmaceuticals B.V., an Oegstgeest, The Netherlands-based clinical-stage immunotherapy company, closed a €26m funding round. Backers included new investors Invest-NL and existing investors including Regeneron. The company intends to us... |
| 13.07.2021 | Regeneron again backs ISA Pharma's HPV program in $30M funding round Age-Appropriate Formulation Development for Pediatric Trials-Challenges and Considerations | Regeneron is once again backing ISA Pharmaceuticals' efforts to move a human papillomavirus treatment towards the market in a €26 million ($30 million) funding round. The company has completed a phase 2 trial of the treatment in vulvar intr... |
| 13.07.2021 | Dutch-based ISA Pharmaceuticals raises €26M to develop immunotherapeutics against cancer and viral infections | Netherlands-based ISA Pharmaceuticals is an immunotherapy company that develops treatments for various cancers and infectious diseases. In a recent development, the company has raised €26M in a fresh round of funding. The fundraise saw part... |
| 13.07.2021 | Regeneron again backs ISA Pharma's HPV program in $30M funding round | Regeneron is once again backing ISA Pharmaceuticals' efforts to move a human papillomavirus treatment towards the market in a €26 million ($30 million) funding round. The Dutch biotech will use the funding to bankroll the advancement of thr... |